Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01229527Phase 4Completed
Phase 4, randomised, double-blind trial of remifentanil in colonoscopy, sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Time to Reach a Modified Aldrete Score ≥18. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01229527.